Psyence Biomedical Ltd (PBM)
0.83
+0.03
(+4.01%)
USD |
NASDAQ |
Apr 25, 13:11
Psyence Biomedical Free Cash Flow (Quarterly): -1.595M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -1.595M |
| Date | Value |
|---|---|
| September 30, 2022 | -0.5681M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-1.595M
Minimum
Sep 2023
-0.5681M
Maximum
Sep 2022
-1.082M
Average
-1.082M
Median
Free Cash Flow (Quarterly) Benchmarks
| Lucy Scientific Discovery Inc | -0.7395M |
| Lexaria Bioscience Corp | -0.6766M |
| Acasti Pharma Inc | -1.892M |
| Aurinia Pharmaceuticals Inc | 14.25M |
| Edesa Biotech Inc | -1.406M |